Serum level of N-terminal propeptide of type I procollagen in people of various ages and gender
Keywords:bone turnover markers, N-terminal propeptide of type I procollagen, age, sex
Background. The purpose of the study is to determine the serum level of N-terminal propeptide of type I procollagen (PINP) in healthy men and women of various ages. Materials and methods. The study included 1,568 individuals (1,422 females and 146 males, aged 20-89 years (mean age 60.36 ± 13.68 yrs). All patients were divided into 7 groups, by decades and according to the gerontological age classification: young age – 20–44 yrs, middle age 45–59 yrs, elderly 60–74 yrs, and old 75-89 yrs. During the study, we examined the effect of such demographic characteristics, as age and gender, on serum PINP level, using the electrochemiluminescence immunoassay ECLIA on the cobas e 411 analyzer. Results. We have detected no significant effect of age on the serum variability of PINP in females (F = 1.453, p = 0.19). However, we observed a significant decrease of PINP level in the female age groups of 40–49 yrs (47.74 ± 21.31, p = 0.02), 60–69 yrs (49.76 ± 25.75, p = 0.03), 70–79 yrs (50.49 ± 26.71, p = 0.04), compared with the age group of 20–29 yrs (58.67 ± 27.46). The regression analysis revealed a significant decrease of PINP level with age in young women and men (20–44 years). When comparing serum PINP level in the oldest age group (80-89 years), we detected its increase in women (55.20 ± 28.38 ng/ml), compared with the 70–79 years group (50.49 ± 26.71 ng/ml), and its decrease in men (54.87 ± 28.24 and 39.16 ± 12.46 ng/ml, respectively). In men, we revealed significant effect of age on the serum variability of PINP (F = 3,077, p = 0.007). Conclusions. The regression analysis showed a significant decrease in PINP level with age in men and women of 20-44 years. In men, we detected a significant effect of age on the variability of serum PINP level. A comparison of serum PINP levels in the oldest age group of 80-89 revealed its increase in women, compared to the 70–79 age group, and decrease in men. The obtained results may be used as reference values for PINP level in serum among representatives of the Ukrainian population of various ages and sexes.
Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV. Bone turnover markers: Emerging tool in the management of osteoporosis. Indian J Endocrinol Metab. 2016;20(6):846–852. https://doi.org/10.4103/2230-8210.192914.
Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005;26(4):97–122.
Roodman GD, Guise TA. Bone and Cancer. In: Burr DB, Allen MR, editors. Basic and Applied Bone Biology. 2th ed. USA: Academic Press; 2019. 411-423 pp. https://doi.org/10.1016/B978-0-12-813259-3.00022-1.
Szulc P, Naylor K, Hoyle NR, Eastell R, Leary ET; National Bone Health Alliance Bone Turnover Marker Project. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporos Int. 2017;28(9):2541–2556. https://doi.org/10.1007/s00198-017-4082-4.
Coates P. Bone turnover markers. Aust Fam Physician. 2013;42(5):285–287.
Povoroznyuk VV, Balatska NI. Role of bone tissue turnover markers in diagnosis of osteoporosis. Mystetstvo likuvannya. 2013;2–3:98–99. (in Ukrainian).
Povoroznyuk VV. Osteoporosis and biochemical bone turnover markers. Laboratory diagnosis. 2002;1:53–61. (in Ukrainian).
Redmond J, Fulford AJ, Jarjou L, Zhou B, Prentice A, Schoenmakers I. Diurnal Rhythms of Bone Turnover Markers in Three Ethnic Groups. J Clin Endocrinol Metab. 2016;101(8):3222–3230. https://doi.org/10.1210/jc.2016-1183.
Povoroznyuk VV, Grygorieva N.V. Menopause and osteoporosis. Mystetstvo likuvannya. 2005;3:25–30. (in Ukrainian).
State Statistics Service of Ukraine. Fertility, mortality, and average life expectancy tables for 2018. Kyiv; 2019. 66 p.
Eurostat. Life expectancy at birth in the EU: men vs. women. 2017. Available from: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/DDN-20190725-1
Vasikaran S, Eastell R, Bruyère O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391–420. https://doi.org/10.1007/s00198-010-1501-1.
Garnero P, Szulc P. Assessment of Bone Turnover in Men Using Biochemical Markers. In: Orwoll E, Bilezikian J, Vanderschueren D, editors. Osteoporosis in Men. 2nd ed. Academic Press; 2009. 25-40 pp. https://doi.org/10.1016/B978-0-12-374602-3.00003-1.
Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5(11):908–923. https://doi.org/10.1016/s2213-8587(17)30184-5.
Kitareewan W, Boonhong J, Janchai S, Aksaranugraha S. Effects of the treadmill walking exercise on the biochemical bone markers. J Med Assoc Thai. 2011;94 Suppl 5:S10–S16.
Aaron JE, Makins NB, Sagreiya K. The microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop Relat Res. 1987;(215):260–271.
Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003;88(10):4623–4632. https://doi.org/10.1210/jc.2003-030358.
Ferreira A, Alho I, Casimiro S, Costa L. Bone remodeling markers and bone metastases: From cancer research to clinical implications. Bonekey Rep. 2015;4:668. https://doi.org/10.1038/bonekey.2015.35.
Weiler R, Keen R, Wolman R. Changes in bone turnover markers during the close season in elite football (soccer) players. J Sci Med Sport. 2012;15(3):255–258. https://doi.org/10.1016/j.jsams.2011.09.004.
How to Cite
Copyright (c) 2020 V.V. Povoroznyuk, N.V. Zaverukha, T.Y. Solonenko
This work is licensed under a Creative Commons Attribution 4.0 International License.